VIENNA--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today reported on the Company’s therapeutic platforms utilizing oral immune regulation for immune mediated diseases at the Bio-Europe 2009 15th Annual International Conference here calling it a “bright area of therapeutic promise.”
